New cancer pill enters human testing for advanced tumors
Disease control
Recruiting now
This early-phase trial is testing an experimental oral drug called OCT-598 in 51 adults with advanced solid tumors, including breast, lung, and prostate cancers. The study aims to find the safest dose and see if the drug works alone or with standard chemotherapy. It is too early …
Phase: PHASE1 • Sponsor: Oscotec Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC